메타콜린 기관지유발검사 시행방법: 대한천식알레르기학회 의견서
Report on the methacholine bronchial provocation test protocol: An updated statement of Korean Academy of Asthma, Allergy and Clinical Immunology
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The Korean Academy of Asthma, Allergy, and Clinical Immunology task force report aims to provide new protocols for methacholine challenge test (MCT). Although new devices have different delivery system compared to old ones, previous protocols are still used, which cannot guarantee adequate diagnoses of asthma. Another important issue is the recent recommendation in European Respiratory Society (ERS) technical standard guideline to use a delivered methacholine dose that causes a 20% decrease in forced expiratory volume in 1 second (FEV1) (PD20). Although the previous protocol based on the methacholine concentration causing a 20% decrease in FEV1 (PC20) has been used globally, several studies have reported that PD20 is more reliable and applicable for new protocols of MCT. Indeed, a tidal breathing inhalation protocol using a breath-actuated or continuous nebulizer is recommended. Herein, we recommend 3 protocols for the MCT using new devices and provide a brief summary of the change in strategy based on the updated ERS guideline.
Abstract
The Korean Academy of Asthma, Allergy, and Clinical Immunology task force report aims to provide new protocols for methacholine challenge test (MCT). Although new devices have different delivery system compared to old ones, previous protocols are still used, which cannot guarantee adequate diagnoses of asthma. Another important issue is the recent recommendation in European Respiratory Society (ERS) technical standard guideline to use a delivered methacholine dose that causes a 20% decrease in forced expiratory volume in 1 second (FEV1) (PD20). Although the previous protocol based on the methacholine concentration causing a 20% decrease in FEV1 (PC20) has been used globally, several studies have reported that PD20 is more reliable and applicable for new protocols of MCT. Indeed, a tidal breathing inhalation protocol using a breath-actuated or continuous nebulizer is recommended. Herein, we recommend 3 protocols for the MCT using new devices and provide a brief summary of the change in strategy based on the updated ERS guideline.
참고문헌 (26)
- McCracken JL, "Diagnosis and management of asthma in adults : a review", JAMA, 318, pp.279~290 (2017)
- Crapo R, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- Prieto L, "Differences in the response to methacholine between the tidal breathing and dosimeter methods : influence of the dose of bronchoconstrictor agent delivered to the mouth", Chest, 134, pp.699~703 (2008)
- Coates AL, "ERS technical standard on bronchial challenge testing : general considerations and performance of methacholine challenge tests", Eur Respir J, 49, pp.1601526~ (2017)
- 임경환, "기관지유발검사 시행과 해석: 전문가 의견서", Allergy Asthma & Respiratory Disease, 6(1), pp.14~25 (2018), 대한 소아알레르기 호흡기학회[DOI]
- Adkinson Jr NF, "Middleton's allergy E-Book : Principles and practice" (2013), Elsevier Health Sciences
- Graham BL, "Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement", Am J Respir Crit Care Med, 200, pp.e70~e88 (2019)
- Patel K, "Sodium cromoglycate in histamine and methacholine reactivity in asthma", Clin Allergy, 14, pp.143~145 (1984)
- Davis BE, "Effect of a single dose montelukast sodium on methacholine chloride PC20", Can Respir J, 12, pp.26~28 (2005)
- Coates AL, "The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols", Chest, 111, pp.1206~1212 (1997)
- Merget R, "Development of a 1-concentration-4-step dosimeter protocol for methacholine testing", Respir Med, 103, pp.607~613 (2009)
- Schulze J, "Methacholine challenge–comparison of an ATS protocol to a new rapid single concentration technique", Respir Med, 103, pp.1898~1903 (2009)
- Dell SD, "Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers", Ann Am Thorac Soc, 12, pp.357~363 (2015)
- Schmidt LE, "Is an abbreviated bronchial challenge with histamine valid?", Chest, 101, pp.141~145 (1992)
- Jörres RA, "A short protocol for methacholine provocation testing adapted to the Rosenthal-Chai dosimeter technique", Chest, 111, pp.866~869 (1997)
- Segel MJ, "Methacholine challenge testing : improved patient comfort with a 2-tiered protocol", Ann Allergy Asthma Immunol, 110, pp.429~432 (2013)
- Zaczeniuk M, "Methacholine challenge testing is superior to the exercise challenge for detecting asthma in children", Ann Allergy Asthma Immunol, 115, pp.481~484 (2015)
- Cockcroft DW, "The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result", J Allergy Clin Immunol, 117, pp.1244~1248 (2006)
- Cockcroft DW, "Airway hyperresponsiveness. Relevance of random population data to clinical usefulness", Am Rev Respir Dis, 142, pp.497~500 (1990)
- Holzer K, "Exercise in elite summer athletes : challenges for diagnosis", J Allergy Clin Immunol, 110, pp.374~380 (2002)
- Gaillard EA, "European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years", Eur Respir J, 58, pp.2004173~ (2021)
- Greenspon L, "Factors that contribute to inhibition of methacholine-induced bronchoconstriction", Am Rev Respir Dis, 133, pp.735~739 (1986)
- Cockcroft D, "Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine", Thorax, 52, pp.845~848 (1997)
- O’Byrne PM, "Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma", J Allergy Clin Immunol, 124, pp.1217~1221 (2009)
- Illamperuma C, "Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine", Ann Allergy Asthma Immunol, 102, pp.438~439 (2009)
- Blais CM, "Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics", Respir Med, 118, pp.96~101 (2016)